The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, September 14, 2021
Heyan Biotech, located in Wuhan Optics Valley, national biotech industry base, provides for target based in vitro pharmacodynamic screening and early ...
read more
Monday, September 13, 2021
BeiGene, a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and ...
read more
Monday, September 13, 2021
AzurRx BioPharma, a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced that it ...
read more
Monday, September 13, 2021
Navrogen, Inc., a privately held preclinical biotechnology company, announced today that it has entered into a Cooperative Research and Development ...
read more
Thursday, September 09, 2021
Soligenix, a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
read more
Wednesday, September 08, 2021
The FDA revised the guidance for industry Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions and Answers, ...
read more
Tuesday, September 07, 2021
The FDA introduced a new pathway for manufacturers to obtain FDA review of certain novel excipients (inactive ingredients) prior to their use in drug ...
read more
Tuesday, September 07, 2021
Merck’s anti-PD-1 therapy was approved by the National Medical Products Administration (NMPA) in China in combination with platinum- and ...
read more
Friday, September 03, 2021
BeiGene Ltd, a global biotechnology company focused on developing and commercializing innovative medicines worldwide, announced that BRUKINSA® (...
read more
Friday, September 03, 2021
Takeda Pharmaceutical Company Limited announced that the Phase 3 PANTHER (Pevonedistat-3001) study did not achieve pre-defined statistical ...
read more
Friday, September 03, 2021
Impel NeuroPharma Inc., a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high ...
read more
Friday, September 03, 2021
The FDA has approved Invega Hafyera (paliperidone palmitate) extended-release injectable suspension to treat schizophrenia in certain adults. Invega ...
read more
Thursday, September 02, 2021
Astellas Pharma Inc announced that it has voluntarily paused screening and dosing of additional participants in its ASPIRO clinical trial evaluating ...
read more
Thursday, September 02, 2021
FDA Requires Warnings About Increased Risk of Serious Heart-Related Events, Cancer, Blood Clots, and Death for JAK Inhibitors That Treat Certain ...
read more
Wednesday, September 01, 2021
Merck announced a label update for KEYTRUDA Merck’s anti-PD-1 therapy, for its indication in first-line advanced urothelial carcinoma (bladder cancer)...
read more